Chinese english Germany Japanese Korea

1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]-

1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]- Struktur
143565-69-9
CAS-Nr.
143565-69-9
Englisch Name:
1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]-
Synonyma:
1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]-
CBNumber:
CB38388422
Summenformel:
C41H51N7O2
Molgewicht:
673.89
MOL-Datei:
143565-69-9.mol
Request For Quotation

1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]- Eigenschaften

Siedepunkt:
823.0±65.0 °C(Predicted)
Dichte
1.181±0.06 g/cm3(Predicted)
pka
10.32±0.19(Predicted)

Sicherheit

1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
  • 1,3,5-Triazin-2(1H)-one, tetrahydro-1,3-bis(phenylmethyl)-5-[3-[[4-[tetrahydro-4-oxo-3,5-bis(phenylmethyl)-1,3,5-triazin-1(2H)-yl]butyl]amino]propyl]-
  • 143565-69-9
  • C41H51N7O2
Copyright 2019 © ChemicalBook. All rights reserved